P210 Defining the minimal important difference for the visual analogue scale for dyspnoea in patients with malignant pleural effusions

P210 Defining the minimal important difference for the visual analogue scale for dyspnoea in patients with malignant pleural effusions

Dades bibliogràfiques
Autors principals:	Mishra, E, Corcoran, J, Hallifax, R, Stradling, J, Maskell, N, Rahman, N
Format:	Journal article
Publicat:	BMJ Publishing Group 2013

Ítems similars

Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
per: Mishra, E, et al.
Publicat: (2015)

Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
per: Eleanor K Mishra, et al.
Publicat: (2015-01-01)

THE USE OF INDWELLING PLEURAL CATHETERS FOR THE MANAGEMENT OF NON-MALIGNANT RECURRENT PLEURAL EFFUSIONS
per: Bhatnagar, R, et al.
Publicat: (2012)

Modern management of malignant pleural effusions
per: Mercer, R, et al.
Publicat: (2016)

Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set
per: Mercer, RM, et al.
Publicat: (2019)

An unusual cause of progressive dyspnoea, pulmonary nodules and pleural effusions
per: Sudharsan Venkatesan, et al.
Publicat: (2024-01-01)

Biological markers of successful pleurodesis for malignant pleural effusion
per: Psallidas, I, et al.
Publicat: (2016)

Thoracic ultrasonography as a predictor of pleurodesis success in malignant pleural effusion
per: Corcoran, J, et al.
Publicat: (2017)

Thoracic ultrasound as an early predictor of pleurodesis success in malignant pleural effusion
per: Corcoran, J, et al.
Publicat: (2018)

Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion
per: Asciak, R, et al.
Publicat: (2017)

Biological markers of favourable prognosis and successful pleurodesis for malignant pleural effusion
per: Psallidas, I, et al.
Publicat: (2016)

Assessment and treatment of malignant pleural effusions: visual analogue scale, ultrasound and drainage
per: Mishra, EK
Publicat: (2013)

Malignant pleural effusion management: keeping the flood gates shut
per: Walker, S, et al.
Publicat: (2019)

Survival and pleurodesis outcome in patients with malignant pleural effusion – post-hoc analysis from the TIME-1 trial
per: Hassan, M, et al.
Publicat: (2018)

Indwelling pleural catheters for non-malignant effusions: a multicentre review of practice.
per: Bhatnagar, R, et al.
Publicat: (2014)

The palliation of malignant pleural effusions.
per: Bhatnagar, R, et al.
Publicat: (2012)

ERS/EACTS statement on the management of malignant pleural effusions
per: Bibby, A, et al.
Publicat: (2018)

Breathlessness post-drainage predicts survival in patients with malignant pleural effusion
per: Mishra, E, et al.
Publicat: (2018)

Management of malignant pleural effusion
per: McCracken, D, et al.
Publicat: (2018)

Randomised controlled trial of urokinase versus placebo for non-draining malignant pleural effusion
per: Mishra, E, et al.
Publicat: (2018)

Survival And Pleurodesis Response Markers In Malignant Pleural Effusion-The Promise Study
per: Psallidas, I, et al.
Publicat: (2018)

Ultrasound in predicting improvement in dyspnoea after therapeutic thoracentesis in patients with recurrent unilateral pleural effusion
per: Katrine Fjaellegaard, et al.
Publicat: (2024-12-01)

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
per: Ellayeh, M, et al.
Publicat: (2021)

P234 Patient and fluid characteristics associated with non-draining malignant pleural effusion
per: Mishra, E, et al.
Publicat: (2017)

Objective thoracoscopic criteria in differentiation between benign and malignant pleural effusions
per: Ellayeh, M, et al.
Publicat: (2021)

Investigating suspected malignant pleural effusion.
per: Rahman, N, et al.
Publicat: (2007)

Survival in patients with malignant pleural effusion undergoing talc pleurodesis
per: Hassan, M, et al.
Publicat: (2019)

Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.
per: Olfert, J, et al.
Publicat: (2016)

Malignant pleural mesothelioma with resolution of pleural effusion
per: Sayaka Nishida, et al.
Publicat: (2023-11-01)

Derrame pleural neoplásico Malignant pleural effusion
per: Lisete Ribeiro Teixeira, et al.
Publicat: (2006-08-01)

ERS/EACTS statement on the management of malignant pleural effusions
per: Bibby, AC, et al.
Publicat: (2018)

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
per: Ellayeh, MA, et al.
Publicat: (2021)

Biomarkers of malignancy in pleural effusions
per: José M. Porcel, et al.
Publicat: (2024-10-01)

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion.
per: Morel, A, et al.
Publicat: (2011)

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion
per: Morel, A, et al.
Publicat: (2011)

Thoracic ultrasound in the diagnosis of malignant pleural effusion.
per: Qureshi, N, et al.
Publicat: (2009)

Chemotherapy does not increase the risk of pleural infection in patients managed with an indwelling pleural catheter for malignant pleural effusion
per: Morel, A, et al.
Publicat: (2010)

Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial.
per: Maskell, N, et al.
Publicat: (2003)

Summary for clinicians: clinical practice guideline for management of malignant pleural effusions
per: Reddy, C, et al.
Publicat: (2019)

Malignant pleural effusion: From diagnostics to therapeutics.
per: Asciak, R, et al.
Publicat: (2017)